DR info

臨床試験数 : 5 / 薬物数 : 7 - (DrugBank : 5) / 標的遺伝子数 : 22 - 標的パスウェイ数 : 25

薬物ごとの開発者（Primary Sponsor）、臨床試験情報（抜粋）です。

Allopregnanolone
   Randi J. Hagerman, MD
      2015   Phase 2   NCT02603926   United States;
Citocoline
   Rush University Medical Center
      2015   Phase 2   NCT02197104   United States;
Cyclophosphamide
   Children's Oncology Group
      2004   Phase 3   NCT00033293   Australia;Canada;Netherlands;New Zealand;Puerto Rico;Switzerland;United States;
Magnetic resonance imaging
   Children's Oncology Group
      2004   Phase 3   NCT00033293   Australia;Canada;Netherlands;New Zealand;Puerto Rico;Switzerland;United States;
Memantine
   University of California, Davis
      2007   -   NCT00584948   United States;
Prednisone
   Children's Oncology Group
      2004   Phase 3   NCT00033293   Australia;Canada;Netherlands;New Zealand;Puerto Rico;Switzerland;United States;
Sulforaphane
   University of California, Davis
      2021   -   NCT05233579   United States;
Therapeutic immune globulin
   Children's Oncology Group
      2004   Phase 3   NCT00033293   Australia;Canada;Netherlands;New Zealand;Puerto Rico;Switzerland;United States;